MEDP Medpace Holdings PE ratio, current and historical analysis
As at Mar 12, 2025, the MEDP stock has a price-to-earnings ratio of 24.88. This is based on the current EPS of $13.06 and the stock price of $324.91 per share. A decrease of 24% has been recorded in the PE ratio compared to the average of 32.7 of the last four quarters.
MEDP PE ratio history
The mean historical PE ratio of Medpace Holdings over the last nine years is 41.04. The current 24.88 P/E ratio is 39% lower than the historical average. In the past nine years, MEDP's PE ratio peaked in the Sep 2016 quarter at 248.83, with a price of $29.86 and an EPS of $0.12. The Mar 2023 quarter marked the lowest point at 22.99, with a price of $188.05 and an EPS of $8.18.
Medpace Holdings PE ratio by year
Maximum annual increase: 25.76% in 2021
Maximum annual decrease: -61.8% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 25.44 | -23.65% | $332.23 | $13.06 |
| 2023 | 33.32 | 18.75% | $306.53 | $9.2 |
| 2022 | 28.06 | -34.76% | $212.41 | $7.57 |
| 2021 | 43.01 | 25.76% | $217.64 | $5.06 |
| 2020 | 34.2 | 13.51% | $139.2 | $4.07 |
| 2019 | 30.13 | 16.69% | $84.06 | $2.79 |
| 2018 | 25.82 | -28.79% | $52.93 | $2.05 |
| 2017 | 36.26 | -61.8% | $36.26 | $1 |
| 2016 | 94.92 | N/A | $36.07 | $0.38 |
| 2015 | N/A | N/A | N/A | -$0.28 |
Medpace Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 25.44 | -9.85% | $332.23 | $13.06 |
| Sep 2024 | 28.22 | -24.48% | $333.8 | $11.83 |
| Jun 2024 | 37.37 | -5.96% | $411.85 | $11.02 |
| Mar 2024 | 39.74 | 19.27% | $404.15 | $10.17 |
| Dec 2023 | 33.32 | 21.52% | $306.53 | $9.2 |
| Sep 2023 | 27.42 | -1.12% | $242.13 | $8.83 |
| Jun 2023 | 27.73 | 20.62% | $240.17 | $8.66 |
| Mar 2023 | 22.99 | -18.07% | $188.05 | $8.18 |
| Dec 2022 | 28.06 | 21.21% | $212.41 | $7.57 |
| Sep 2022 | 23.15 | -7.03% | $157.17 | $6.79 |
| Jun 2022 | 24.9 | -14.76% | $149.67 | $6.01 |
| Mar 2022 | 29.21 | -32.09% | $163.59 | $5.6 |
| Dec 2021 | 43.01 | 15.9% | $217.64 | $5.06 |
| Sep 2021 | 37.11 | 3.17% | $189.28 | $5.1 |
| Jun 2021 | 35.97 | -1.77% | $176.63 | $4.91 |
MEDP average PE ratio chart
The current PE ratio of MEDP is lower than the 3 and 5-year averages.
MEDP PE vs peers
In comparison to its peer stock ORMP, MEDP's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ORMP Oramed Pharmaceuticals Inc | 21.55 | $95.54M |
| MEDP Medpace Holdings Inc | 24.82 | $9.87B |
| OLMA Olema Pharmaceuticals Inc | N/A | $252.11M |
| OMER Omeros Corp | N/A | $448.24M |
| ONVO Organovo Holdings Inc | N/A | $7.26M |
| ORIC Oric Pharmaceuticals Inc | N/A | $544.07M |
Frequently asked questions
What is Medpace Holdings's PE ratio?
The price to earnings ratio for MEDP stock is 24.88 as of Mar 12, 2025.
What is the 3-year average PE ratio for Medpace Holdings (MEDP)?
As an average over the last 3 years, MEDP stock has a PE ratio of 28.96.
What is the 5-year average PE ratio for Medpace Holdings (MEDP)?
As an average over the last 5 years, MEDP stock has a PE ratio of 31.11.
What is the highest PE ratio for MEDP?
The highest quarterly PE ratio in the last nine years has been 248.83 and it was in the Sep 2016 quarter.
How does the current PE ratio for MEDP compare to its historical average?
MEDP's current price to earnings ratio is 39% below its 9-year historical average.
How is MEDP's PE ratio calculated (Medpace Holdings PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Mar 12, 2025), Medpace Holdings's stock price is $324.91. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $13.06. Therefore, Medpace Holdings's PE ratio for today is 24.88. PE RATIO(24.88) = STOCK PRICE($324.91) / TTM EPS($13.06)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.